BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Lovastatin
,
rs2476601
,
SNCA
,
Fatty acid metabolic process
,
Ischemia
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
recombinant fusion protein
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
BL2 cells stimulated with B cell specific paracrine stimuli
Th2 cytokine IL-4's role in initiating pulmonary vascular inflammation under hypoxia
Anti-viral and anti-proliferative responses to IFNa signaling in Daudi cells
Macrophages from monocytes of donors treated with FVIII or FVIII-Fc fusion protein
Explore Curated Studies Results
Literature
Most Relevant Literature
Pharmacokinetics of recombinant bifunctional fusion proteins.
Engineering of therapeutic and diagnostic O-glycans on recombinant mucin-type immunoglobulin fusion …
PROLONG-9FP clinical development program--phase I results of recombinant fusion protein linking coag…
Construction and expression of recombinant fusion protein of thioredoxin-ApoO.
Expression and purification of recombinant human serum albumin fusion protein with VEGF165b in Pichi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Soli…
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With A…
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ